Clinical Trials Browser

Phase 3 × Neoplasms × Standard of Care × Clear all

NCT07590505 2026-05-15

ULTIMO

Phase 3 Completed

Breast Neoplasms, Neoplasms

NCT02330926 2025-08-29

MENAC

Phase 3 Completed

Cachexia, Neoplasms

NCT04303013 2023-11-01

Guided Meditation During Radiotherapy.

Phase 3 Completed

Neoplasms, Radiation Injuries

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Phase 3 Withdrawn

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive

NCT01310803 2017-10-05

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Phase 3 Terminated

1 enrolled 5 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms